“Metabolic health” appears in headlines, wellness marketing, and physician visits, yet most people, and much of the content written for them, cannot define it precisely. The stakes are significant. A landmark University of North Carolina at Chapel Hill analysis of NHANES data found that only an estimated 12.2% of American adults were metabolically healthy. Separately, roughly 38.7% of US adults now meet criteria for metabolic syndrome.
Much of the confusion comes from three terms being used interchangeably: metabolism, metabolic health, and metabolic syndrome. This explainer traces the term from its biological roots through its clinical history to its most current scientific framing, using a three-tier framework: metabolism, metabolic health, and metabolic syndrome.
The Confusion at the Root: Three Related but Distinct Terms
These terms overlap because they describe the same underlying system from different vantage points, and marketing language often blurs them further. A clearer map treats them as three separate things:
- Metabolism: a biological process
- Metabolic health: a measurable state along a spectrum
- Metabolic syndrome: a diagnosable clinical condition at one end of that spectrum
The rest of this article builds on this map.
Tier One: Metabolism, the Biological Process
Metabolism is the full set of chemical processes by which the body converts food into energy, builds and breaks down tissue, and regulates hormones such as insulin. It includes glucose regulation, lipid processing, and energy storage and expenditure.
No one simply has a “good” or “bad” metabolism in a binary sense. Everyone’s metabolism runs continuously, though at different degrees of efficiency. Metabolic health is best understood as a report card on how well this machinery is functioning.
Tier Two: Metabolic Health, the Measurable State or Spectrum
The most widely cited operational definition requires favorable, medication-free levels across five measures:
- Waist circumference
- Fasting blood glucose
- Blood pressure
- Triglycerides
- HDL cholesterol
There is an important caveat: the literature has no single, universally agreed clinical definition of metabolic health. “Absence of metabolic syndrome” is one of the most commonly used proxy definitions.
Metabolic health is also increasingly understood as a spectrum rather than a pass/fail state. A person can be more or less metabolically healthy without crossing into diagnosable disease. Most online sources present the five-marker checklist as settled fact, but it is a useful, incomplete working definition.
Tier Three: Metabolic Syndrome, the Diagnosable Condition
Metabolic syndrome is the formal diagnosis at the unhealthy end of the spectrum. It is not a synonym for “poor metabolic health” in general. According to NHLBI and AHA criteria, it is diagnosed when three or more of five risk factors are out of range: abdominal obesity, elevated fasting glucose, elevated blood pressure, elevated triglycerides, and low HDL.
The three tiers relate as follows. Metabolism is the process underlying everything. Metabolic health is the broader state that moves toward or away from a diagnosis. Metabolic syndrome is the diagnosis itself. Globally, an estimated 25% of the general population and 70 to 80% of people with type 2 diabetes meet its criteria.
The Historical Lineage: How This Definition Was Built, Decade by Decade
Most consumer content stops at a single 2009 consensus statement. In fact, the definition has evolved over more than 25 years, and that work continues. The milestones are summarized below.
1998: The World Health Organization’s First Formal Definition
The WHO produced the first formalized definition of metabolic syndrome in 1998. It placed insulin resistance at the center and was the first attempt to group separately known risk factors (glucose, lipids, blood pressure, and obesity) into one named syndrome.
2005: AHA/NHLBI Revised Criteria
The American Heart Association and the National Heart, Lung, and Blood Institute simplified the criteria for everyday clinical use. They emphasized waist circumference and blood pressure thresholds that closely resemble today’s markers.
2009: The Harmonized Criteria
A joint interim statement from the IDF, NHLBI, AHA, WHF, IAS, and IASO combined the competing definitions into one. Under this version, abdominal obesity was no longer a mandatory prerequisite. It became one of five equally weighted criteria, and any three of the five constitute a diagnosis. This is still the version most often cited, but it is no longer sufficient as the only reference point.
2023: The AHA’s Cardiovascular-Kidney-Metabolic (CKM) Syndrome Framework
In October 2023, the AHA released a Presidential Advisory on Cardiovascular-Kidney-Metabolic syndrome. The framework treats metabolic health as inseparable from heart and kidney function, reflecting how metabolic dysfunction drives cardiovascular and renal risk over time. Commentary in 2025 and 2026 has followed this direction, describing metabolic-focused medications as tools aimed at total cardiometabolic risk rather than a single number.
Where the Five-Marker Definition Falls Short
The academic literature itself acknowledges gaps in the five-marker model.
- Glucose variability: Fasting glucose is a single snapshot. It does not capture spikes and crashes during the day that may signal early dysfunction before a diagnosis appears.
- Metabolically healthy obesity (MHO): Because no standardized definition exists, estimates of MHO among people with obesity range from roughly 10% to 50%, depending on the criteria used.
Being “within range” on five markers is a useful heuristic, not a settled consensus, which is why individualized clinical judgment matters more than a checklist.
Beyond BMI: The 2025 Lancet Redefinition of Obesity
In January 2025, a Lancet Diabetes & Endocrinology Commission endorsed by more than 75 medical organizations proposed moving beyond BMI. It recommended direct measures of excess adiposity and introduced two categories. Preclinical obesity describes elevated risk without ongoing illness. Clinical obesity describes active organ dysfunction.
Applying excess-adiposity criteria instead of BMI alone raises estimated obesity prevalence to over 60% of US adults. This refines how the metabolic-health spectrum is assessed; it does not replace the underlying concept.
How Common Is Metabolic Health, Really?
- The 2018 UNC study found that only 12.2% of adults, roughly 27.3 million people, met recommended cardiovascular risk targets.
- 66.5% of normal-weight Americans were not in optimal metabolic health, even when waist circumference was excluded.
- NHANES data from 2013 to 2023 show metabolic syndrome holding near 38.7% overall. Among adults 60 and older, it rose from 50.2% to 62.4%.
- Worldwide, prevalence more than doubled from 11.9% in 2000 to 28.4% in 2023, an estimated 1.54 billion adults.
- Levels, a commercial wellness company, reports that 88% of Americans show some metabolic dysfunction. This figure indicates a general direction and is not a clinical consensus statistic.
Across every dataset, the pattern is consistent: metabolic dysfunction is the norm, and it becomes more common with age.
Why This Distinction Matters Beyond a Diagnosis
Metabolic health shapes daily function, including energy, sleep, mood, and cognitive clarity. Dysfunction is often silent. Markers can be measurably poor with no obvious symptoms, which makes the concept valuable as an early warning rather than something people wait to feel.
Clinical discussion has also broadened. Medications once framed narrowly around weight are now discussed in terms of wider effects across the liver, heart, kidneys, and vasculature. Knowing where a person sits on the spectrum is more useful than focusing on any single number.
Metabolic Health as the Organizing Concept Behind Long-Term Care
Taken together, the tiers explain different things. Metabolism explains how the body works. Metabolic health explains where someone stands. Metabolic syndrome explains when it becomes a diagnosis.
This framework supports three parts of care: testing, structured intervention aimed at root causes, and ongoing monitoring. Monitoring matters because metabolic health shifts with age, hormones, and lifestyle, and it is closely tied to perimenopause, andropause, and muscle mass. For this reason, Red Mountain, drawing on more than 30 years of clinical experience, treats it as a continuum of care rather than a single test result.
Conclusion: A Definition Worth Getting Right
Metabolism is the process. Metabolic health is a measurable, dynamic state. Metabolic syndrome is the diagnosable condition. The definition has moved from the WHO’s 1998 framework through the 2009 harmonized criteria to the 2023 CKM framework and the 2025 obesity redefinition, and it will likely keep evolving. Metabolic health is best understood as a lifelong, modifiable spectrum, which is why it works as an organizing concept for care.
Next Step: Understanding Where You Stand
Once the concept is clear, the natural next question is where an individual’s own metabolic health stands. Answering it requires actual testing and clinical interpretation, not self-diagnosis from an article. That personalized assessment is what a clinical consult with Red Mountain’s in-person providers is designed to provide.
